DMALL (02586) repurchased 200,300 shares for HK$1,707,800 on October 12.
Dmall (02586) announced that on October 12, 2026, the company repurchased 200,300 shares for HK$1.7078 million.
DMALL (02586) announced that on October 12, 2026, the company repurchased 200,300 shares for HK$1.7078 million.
Related Articles
CHINANEWTOWN (01278): As of the end of September, the total investment portfolio of fixed-income projects was approximately RMB 3.073 billion.
Sichuan Biokin Pharmaceutical (688506.SH): Yizekang new indication included in priority review process
ASIASEC PPT (00271) proposes a "10-into-1" share consolidation, followed by a rights issue on a "1-for-1" basis.
CHINANEWTOWN (01278): As of the end of September, the total investment portfolio of fixed-income projects was approximately RMB 3.073 billion.
Sichuan Biokin Pharmaceutical (688506.SH): Yizekang new indication included in priority review process
ASIASEC PPT (00271) proposes a "10-into-1" share consolidation, followed by a rights issue on a "1-for-1" basis.
